Skip to content

Genetic Study of Sitosterolemia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00004481
Enrollment
Unknown
Registered
1999-10-19
Start date
1999-11-30
Completion date
Unknown
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipid Metabolism, Inborn Errors, Sitosterolemia

Keywords

endocrine disorders, inborn errors of metabolism, rare disease, sitosterolemia

Brief summary

OBJECTIVES: I. Identify the genetic defect and fine map the gene that causes sitosterolemia.

Detailed description

PROTOCOL OUTLINE: Patients, family members, and normal volunteers provide blood samples for genetic studies and may fill out a general health and medication history. Linkage analysis and microsatellite screening is performed on genomic DNA, especially chromosome 2p21, between microsatellite markers D2S1788 and D2S1352. Positive results may be reported to the patient and may influence future treatment.

Interventions

PROCEDUREgenetic testing

Sponsors

Medical University of South Carolina
CollaboratorOTHER
National Center for Research Resources (NCRR)
Lead SponsorNIH

Study design

Observational model
NATURAL_HISTORY

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- * Diagnosis of sitosterolemia Presence of tendon and tuberous xanthomas Premature atherosclerotic disease No family history of premature coronary artery disease Normal or elevated plasma cholesterol levels OR * Family member of patient with sitosterolemia OR * Normal volunteer

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026